Health tech startup launches Trust for investing 5% of future proceeds

AFRICA – 54gene, a health tech startup, is creating a Trust which it will use to invest up to 5% of future proceeds from the company’s commercial drug discovery program. The creation of the trust is part of its Commitment to Africa in establishing a more sustainable and thriving cyclical ecosystem across Africa’s scientific development space, as well as ensuring better quality healthcare delivery for the communities in which the company operates. 54gene is focused on creating a pipeline of novel drugs for global populations, based on insights drawn from…

Read More